Rhumbline Advisers Increases Position in Cartesian Therapeutics, Inc. (NASDAQ:RNAC)
Rhumbline Advisers increased its stake in shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) by 27.5% during the first quarter, Holdings Channel.com reports. The institutional investor owned 13,006 shares of the company’s stock after buying an additional 2,805 shares during the quarter. Rhumbline Advisers’ holdings in Cartesian Therapeutics were worth $171,000 as of its […]
Rhumbline Advisers increased its stake in shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) by 27.5% during the first quarter, Holdings Channel.com reports. The institutional investor owned 13,006 shares of the company’s stock after buying an additional 2,805 shares during the quarter. Rhumbline Advisers’ holdings in Cartesian Therapeutics were worth $171,000 as of its […]
